David T. Miyamoto

Also affiliated with Harvard University, Massachusetts General Hospital, Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers”.

Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers

Urologic Clinics of North America(2022)10.1016/j.ucl.2022.09.010

N/A

0.330DataRank · unranked

8 citations

Richard J. Lee, David T. Miyamoto, Ikenna Madueke

Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.09.043

N/A

0.330DataRank · unranked

8 citations

Beow Y. Yeap, Jeff M. Michalski, Nora Horick, Anthony L. Zietman, John P. Christodouleas +15 more

Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition

Cancer Research(2022)10.1158/0008-5472.can-21-2609

N/A

0.269DataRank · unranked

5 citations

Yu Zheng, Taronish D. Dubash, Risa Burr, Douglas S. Micalizzi, Ben S. Wittner +19 more

EA8185: Phase 2 study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node positive urothelial carcinoma (INSPIRE)—An ECOG-ACRIN and NRG Collaboration.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps4590

N/A

0DataRank · unranked

0 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.42378

N/A

0DataRank · unranked

13 citations

Jennifer Moughan, David T. Miyamoto, Jeff Simko, William U. Shipley, Phillip J. Gray +20 more

EA8185: Phase 2 study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node-positive urothelial carcinoma (INSPIRE), an ECOG-ACRIN/NRG collaboration.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4617

N/A

0DataRank · unranked

4 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

EA8185: Phase 2 study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node positive urothelial carcinoma (INSPIRE), an ECOG-ACRIN/NRG collaboration.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.tps594

N/A

0DataRank · unranked

0 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0792

N/A

0DataRank · unranked

17 citations

Yuzhen Zhou, Keisuke Otani, Michael Drumm, Yukako Otani, Shulin Wu +17 more

Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712

European Urology Oncology(2024)10.1016/j.euo.2024.03.015

N/A

0DataRank · unranked

2 citations

Sophia C. Kamran, Amol C. Shetty, Philip Sutera, Yang Song, Soha Bazyar +29 more

Imposter among us: field cancerization in the bladder

Translational Andrology and Urology(2024)10.21037/tau-24-8

N/A

0DataRank · unranked

2 citations

Ella Chung, Rea Pittie, David T. Miyamoto, Daniel J . Rodden

Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer

European Urology(2021)10.1016/j.eururo.2020.12.037

N/A

0DataRank · unranked

94 citations

Alejandro Athie, Paul C. Boutros, Marzia Del Re, David T. Miyamoto, Kenneth J. Pienta +6 more

Predictive Model of Acute Rectal Toxicity in Prostate Cancer Treated With Radiotherapy

JCO Clinical Cancer Informatics(2025)10.1200/cci-24-00252

N/A

0DataRank · unranked

2 citations

Beow Y. Yeap, Hoyeon Lee, Z. Soetan, M. Moteabbed, Stacey Muise +12 more

EA8185: Phase II study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node-positive urothelial carcinoma (INSPIRE), ECOG-ACRIN/nrg collaboration.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps500

N/A

0DataRank · unranked

4 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

Single cell proteomics of tumor compartments identifies differential kinase activities defining sensitivity to mTOR-PI3-kinase inhibition

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.06.425147

N/A

0DataRank · unranked

0 citations

Yu Zheng, Taronish D. Dubash, Risa Burr, Douglas S. Micalizzi, Ben S. Wittner +14 more